Funded Startups in Haifa
Among the 16 most recent Haifa-area rounds shown, the largest disclosed amount is proteanTecs’ $51M (Series D) closed on 2025-09-14.
Among the 16 most recent Haifa-area rounds shown, the largest disclosed amount is proteanTecs’ $51M (Series D) closed on 2025-09-14. The next-largest disclosed round is Droxi’s $21M (Series A) on 2024-12-03, so the $51M entry materially outweighs the rest of the disclosed amounts in this set. Disclosed amounts also cluster in two adjacent recent quarters: three of the 16 rows have round dates in September 2025 (Feelit $8M on 2025-09-17; proteanTecs $51M on 2025-09-14; NurExone Biologic $560K on 2025-08-20).
Stage and disclosure patterns show additional compression. Four of the 16 entries are labeled “Series Unknown” (NurExone Biologic 2025-08-20; Ever After Foods 2024-06-18; GrayMatters Health 2023-03-20; plus one blank/unspecified stage entry—BreezoMeter 2021-06-28 has no stage listed), while two entries list amounts as “undisclosed” (FVMat 2023-03-16; Magentiq Eye Ltd 2022-12-23; Maygia 2022-10-03). Sector-wise, AI appears three times (Droxi 2024-12-03 $21M; Captain’s Eye 2022-06-28 $4M; Pruvo 2020-03-20 $1M), and the date range spans from 2020-03-20 to the latest 2025-09-17.
Most recent rounds
16 shownRelated listings
Frequently asked
What stands out as the biggest disclosed round in Haifa here, and how far ahead is it versus the rest of the disclosed amounts?
proteanTecs’ $51M (Series D) on 2025-09-14 is the only disclosed round above $50M in this list. The next-largest disclosed amount is Droxi’s $21M (Series A) on 2024-12-03, making the $51M round a clear outlier versus the rest of the disclosed figures.
Do the most recent rounds concentrate into a narrow window (last ~90 days) or are they evenly spread?
There is a tight cluster in late summer to mid-September 2025: NurExone Biologic closed on 2025-08-20 for $560K, proteanTecs on 2025-09-14 for $51M, and Feelit on 2025-09-17 for $8M. Beyond that, the remaining disclosed entries are more spread across 2024 down to 2020, with fewer very recent dates after September 2025.
How much of the listing is hard to benchmark because the stage or amount is missing (“Series Unknown” and “undisclosed”)?
Five of the 16 rows involve missing or non-standard disclosure: four entries are explicitly “Series Unknown” (NurExone Biologic 2025-08-20; Ever After Foods 2024-06-18; GrayMatters Health 2023-03-20; plus another Series Unknown entry is not present—BreezoMeter instead has a blank stage on 2021-06-28) and three entries show “undisclosed” amounts (FVMat 2023-03-16; Magentiq Eye Ltd 2022-12-23; Maygia 2022-10-03). Separately, some rows have a stage label present but a blank/unspecified stage name (e.g., BreezoMeter 2021-06-28; Regulus Cyber 2020-05-18; Pruvo 2020-03-20).
Which sectors appear often enough to form a pattern in this Haifa list?
Artificial Intelligence-related companies account for three of the 16 entries: Droxi (AI) at $21M on 2024-12-03, Captain’s Eye (AI) at $4M on 2022-06-28, and Pruvo (AI) at $1M on 2020-03-20. Hardware (Feelit 2025-09-17 $8M; FVMat 2023-03-16 undisclosed) also appears more than once, but less consistently than AI.
Are there any notably small disclosed rounds that could skew comparisons within the disclosed set?
The smallest disclosed amount is Pruvo’s $1M on 2020-03-20 (AI, stage unspecified). Several other small disclosed figures sit near the $300K–$4M range (Kiinns $300K on 2022-12-20; Captain’s Eye $4M on 2022-06-28; Regulus Cyber $4M on 2020-05-18), which contrasts sharply with the upper end of $21M and $51M among disclosed rounds.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.